Form 4: Apollomics Director Yi-An Chu Exercises RSU Vesting

Director Yi-An Chu acquired 500 Class A Ordinary Shares of Apollomics Inc. through the vesting of restricted stock units.

Summary

• Director Yi-An Chu acquired 500 Class A Ordinary Shares on June 15, 2026.
• The acquisition resulted from the vesting of restricted stock units (RSUs).
• Following this transaction, the director holds a total of 1,500 Class A Ordinary Shares.
• The transaction was executed at a price of $0 per share as part of a previously reported equity compensation plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard equity compensation vesting rather than a strategic market move.

Positives

• Director maintains a direct ownership stake in the company, aligning interests with shareholders.

Negatives

• None identified.

Risks

• Future vesting schedules may impact share dilution if new shares are issued.

Future Outlook

The filing notes that an additional 500 shares are scheduled to vest on September 15, 2026.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of equity compensation vesting for a corporate director, which is standard practice for publicly traded biotechnology firms.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for equity-based director compensation.
• The disclosure complies with SEC Section 16(a) reporting requirements.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Final RSU vesting of 500 shares scheduled for September 15, 2026.

Key Dates

Keywords

Apollomics, APLM, Form 4, Insider Trading, Director Ownership, Restricted Stock Units